Australia's largest stock trading and investment forum Australia's #1 stock forum

simple people look at buying price only business looks at cost...

First 519 Last

Share
Profile

Follow
pintohoo

95,991 Posts.

75

04/12/23

18:10

Post #: 71264041
Share

Originally posted by Sweetsound ↑

Should start with car price comparisons:

https://www.whichcar.com.au/reviews/2023-mazda-6-review-australian-first-drive

Excerpt:

The five-strong Mazda 6 range provides an option for almost everyone, with a sedan or wagon available for each grade.

It opens with the entry-level G25 Sport at $35,540 before on-road costs,
while the flagship 20th Anniversary wagon tops the range at $54,935 plus on-roads.

https://www.carsguide.com.au/tesla/model-3

Excerpt:

The Tesla Model 3 line-up currently starts at $57,400 for the Model 3 Rear-Wheel Drive and
ranges through to $91,600 for the range-topping Model 3 Performance.

There is a $21k price difference at entry level and a whopping $36k on the top level for the two cars. Doctors can afford such - the average working person not so much.

Any saving in fuel costs pales in significance for the cost difference in the two car types. But then why would a doctor worry about fuel cost anyway - most are probably more likely to worry about status and keeping up appearances rather than practicality. Any practical person should see that the ICE vehicle offers better value. AIMO

Expand

simple people look at buying price only

business looks at cost of ownership

surely a far smarter way.
2 Upvote

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 519 Last

SPONSORED BY